FAZE MEDICINES

faze-medicines-logo

Faze Medicines is a biotechnology company that uses a variety of screening and proteomics techniques to define condensate interaction networks.

#SimilarOrganizations #People #Financial #Event #Website #More

FAZE MEDICINES

Social Links:

Industry:
Biotechnology Chemical

Founded:
2020-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.fazemed.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
81 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics


Similar Organizations

aracari-biosciences-logo

Aracari Biosciences

Aracari is a Drug discovery company.

atavistik-bio-logo

Atavistik Bio

Atavistik Bio is a biotechnology company that focuses on the discovery and development of novel therapies for metabolic diseases and cancer.

biprocel-logo

Biprocel

Biprocel is a biotechnological company.

not_available_image

E-Seq Medical

E-Seq Medical is a biotech company

eyebiotech-logo

Eyebiotech

Eyebiotech is a privately held ophthalmology biotechnology company.

farmfes-logo

FARMFES

FARMFES is a agtech company

forcyte-biotechnologies-logo

Forcyte Biotechnologies

Forcyte Biotechnologies is a Biotech Company.

in-diagnostics-logo

In Diagnostics

In Diagnostics is a Biotechnology company

innovogene-biosciences-logo

InnovoGENE biosciences

InnovoGENE biosciences is a research driven biotechnology company.

iota-biosciences-logo

Iota Biosciences

Iota Biosciences is a Biotech Company.

lavie-bio-logo

Lavie bio

Lavie bio is an innovative company.

mnemo-therapeutics-logo

Mnemo Therapeutics

Mnemo Therapeutics specializes in biotechnology and life science.

mojia-bioscience-logo

Mojia Bioscience

Mojia Bioscience is a biotechnology company.

occulo-holdings-logo

Occulo Holdings

Occulo Holdings is a Biotechnology Company.

ovagen-logo

Ovagen

Ovagen is a biotechnology company.

primmune-therapeutics-logo

Primmune Therapeutics

Primmune Therapeutics is a Biotechnology company.

recida-therapeutics-logo

Recida Therapeutics

Recida Therapeutics is a Biotechnology company.

regeltec-logo

ReGelTec

ReGelTec is a medical device company.

repertoire-immune-medicines-logo

Repertoire Immune Medicines

Repertoire Immune Medicines is a clinical stage biotechnology company.

savefruit-logo

Savefruit

Savefruit is a biotechnology company.

scipio-bioscience-logo

Scipio Bioscience

A Paris-based biotechnology company .

sexton-biotechnologies-logo

Sexton Biotechnologies

Sexton Biotechnologies is a biotechnology company.

sona-nanotech-ltd-logo

Sona Nanotech Ltd.

Sona Nanotech Ltd. is a nano technology life science firm.

stilla-technologies-logo

Stilla Technologies

Stilla Technologies is a Paris-based european biotechnology company.

themis-bioscience-logo

Themis Bioscience

Themis Bioscience is a start-up biotechnology company.

tikomed-logo

TikoMed

TikoMed is a biotechnology company.


Current Advisors List

cary-pfeffer_image

Cary Pfeffer Board Member @ Faze Medicines
Board_member
2020-12-10

charles-homcy_image

Charles Homcy Board Member @ Faze Medicines
Board_member
2020-12-10

robert-tepper_image

Robert Tepper Board Member @ Faze Medicines
Board_member
2020-12-10

laura-brass_image

Laura Brass Board Member @ Faze Medicines
Board_member
2020-12-10

charles-kunsch_image

Charles Kunsch Board Observer @ Faze Medicines
Board_observer
2020-12-01

Current Employees Featured

not_available_image

Ron Vale
Ron Vale Scientific Co-Founder @ Faze Medicines
Scientific Co-Founder

daryn-lewis_image

Daryn Lewis
Daryn Lewis SVP, Head of People & Culture @ Faze Medicines
SVP, Head of People & Culture
2021-08-01

not_available_image

Mike Rosen
Mike Rosen Scientific Co-Founder @ Faze Medicines
Scientific Co-Founder

not_available_image

J. Paul Taylor
J. Paul Taylor Scientific Co-Founder @ Faze Medicines
Scientific Co-Founder

renรฉ-m-lemieux_image

Renรฉ M. Lemieux
Renรฉ M. Lemieux Senior Vice President @ Faze Medicines
Senior Vice President
2020-12-01

jim-hampe_image

Jim Hampe
Jim Hampe Chief Business Officer @ Faze Medicines
Chief Business Officer
2020-12-01

edward-freedman_image

Edward Freedman
Edward Freedman Chief Financial Officer @ Faze Medicines
Chief Financial Officer

rachel-meyers_image

Rachel Meyers
Rachel Meyers Chief Scientific Officer @ Faze Medicines
Chief Scientific Officer
2020-12-01

not_available_image

Roy Parker
Roy Parker Scientific Co-Founder @ Faze Medicines
Scientific Co-Founder

phil-vickers_image

Phil Vickers
Phil Vickers President and CEO @ Faze Medicines
President and CEO
2021-01-01

Founder


not_available_image

J. Paul Taylor

not_available_image

Mike Rosen

not_available_image

Ron Vale

not_available_image

Roy Parker

Investors List

third-rock-ventures_image

Third Rock Ventures

Third Rock Ventures investment in Series A - Faze Medicines

catalio-capital-management_image

Catalio Capital Management

Catalio Capital Management investment in Series A - Faze Medicines

eli-lilly_image

Eli Lilly

Eli Lilly investment in Series A - Faze Medicines

casdin-capital_image

Casdin Capital

Casdin Capital investment in Series A - Faze Medicines

invus_image

Invus

Invus investment in Series A - Faze Medicines

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series A - Faze Medicines

alexandria-venture-investments_image

Alexandria Venture Investments

Alexandria Venture Investments investment in Series A - Faze Medicines

abbvie-biotech-ventures_image

AbbVie Biotech Ventures

AbbVie Biotech Ventures investment in Series A - Faze Medicines

Official Site Inspections

http://www.fazemed.com Semrush global rank: 5.54 M Semrush visits lastest month: 1.53 K

  • Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
  • IP address: 15.197.148.33
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Faze Medicines"

Faze Medicines - Crunchbase Company Profile & Funding

Organization. Faze Medicines . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email โ€ฆSee details»

Faze Medicines - LinkedIn

Faze Medicines is a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular condensates. Our entire team is excited by the opportunity to harness this ...See details»

Faze Medicines Company Profile | Management and Employees โ€ฆ

Www.fazemed.com . Faze Medicines Profile and History. Faze Medicines is a biotechnology company harnessing the groundbreaking new science of biomolecular condensates to create โ€ฆSee details»

Faze Medicines Company Profile 2024: Valuation, โ€ฆ

Faze Medicines General Information Description. Operator of a biotechnology company intended to pioneer therapeutics based on biomolecular condensates. The company engages in research for therapies using various screening and โ€ฆSee details»

Faze Medicines, Inc. - Drug pipelines, Patents, Clinical trials

Www.fazemed.com. Last update 28 Sep 2024See details»

Faze Medicines Overview | SignalHire Company Profile

Faze Medicines is a private company that has been in the industry for 4 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is โ€ฆSee details»

Faze Medicines - VentureRadar

Similar Companies: PellePharm USA Privately Held PellePharm, Inc.is a biotechnology company which develops skin cancer therapeutics. The company provides oral medications for basal โ€ฆSee details»

Faze Medicines - Overview, News & Similar companies - ZoomInfo

View Faze Medicines (www.fazemed.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees by title and โ€ฆSee details»

Faze Medicines, Inc. Asset Profile | Preqin

Founded in 2020 and based in Massachusetts, US, Faze Medicines, Inc. operates as a developer of therapeutics based on biomolecular condensates focus on resea...See details»

www.fazemed.com

Www.fazemed.comSee details»

Faze Medicines Appoints New Senior Vice President, โ€ฆ

Aug 5, 2021 Daryn Lewis brings more than 15 years of experience in the pharmaceutical and technology industries. BOSTON, Aug. 5, 2021 /PRNewswire/ -- Faze Medicines, a biotechnology company pioneering therapeutics based โ€ฆSee details»

Faze Medicines Overview - Salary.com

Discover essential details about Faze Medicines, including address, contact, and journey of our company's evolution.See details»

Faze Medicines Appoints New Senior Vice President, Head of โ€ฆ

Aug 5, 2021 Prior to joining Faze Medicines, she played an instrumental role in growing EnerNOC, an energy service and solutions provider, to a 1,400-employee global organization โ€ฆSee details»

Faze Medicines Appoints Biotech Leader Philip Vickers, Ph.D

Jan 25, 2021 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Faze Medicines, a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular โ€ฆSee details»

Faze Medicines Appoints Douglas Kerr, M.D., Ph.D., to its

May 4, 2021 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Faze Medicines, a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular โ€ฆSee details»

Faze Medicines Launches With $81 Million Series A ... - Business Wire

Dec 10, 2020 For more information, visit fazemed.com. Contacts. Adam Silverstein Ten Bridge Communications [email protected] (917) 697-9313 Contacts.See details»

Faze Medicines Appoints Daryn Lewis SVP, Head of People & Culture

Faze Medicines, a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular condensates, today announced that Daryn Lewis has joined the โ€ฆSee details»

Faze Medicines Appoints Biotech Leader Philip Vickers

Jan 25, 2021 For more information, visit fazemed.com. Contacts. Gwen Schanker Ten Bridge Communications [email protected] (269)-921-3607 Release Summary.See details»

Faze Medicines Launches With $81 Million Series A ... - Condensates

Dec 10, 2020 CAMBRIDGE, Mass.โ€“(BUSINESS WIRE)โ€“Faze Medicines, a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular โ€ฆSee details»

Faze Medicines Email Format | fazemed.com Emails

[email protected]: 100.0%. Email Verification Tool Instantly check any Microsoft email. Get free lookups per month. Verify Top Faze Medicines Employees Jeff Hixon Senior Director of โ€ฆSee details»

linkstock.net © 2022. All rights reserved